Delivery Order SPE2DB20D2104-SPE2DB23FU35G
- Not listed
- This federal contract award, valued at $13,935.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a delivery order for the provision of CIBINQO 100 MG TABLET pharmaceutical products. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,511.02 firm fixed-price delivery order contract covers the supply of CIBINQO 100 MG TABLET UU 30S, a medical product, with a performance period extending through March 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,798.89 firm fixed-price delivery order contract is for the supply of the pharmaceutical product CIBINQO 100 MG TABLET UU 30S, with a period of performance through November 27, 2024. The contract is not designated as a set-aside and represents an order under Amerisourcebergen's larger $999,999,999 Indefinite...
- This federal contract award is for the delivery of Cibinqo 100 mg tablets to the Defense Logistics Agency (DLA). The $10,170.01 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 28, 2023. The contract has an ultimate completion date of December 29, 2023 and is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $73,657.37 firm fixed-price contract is for the supply of CIBINQO 100 MG TABLET UU 30S, a medical product. The contract has an ultimate completion date of April 21, 2023 and was awarded on April 20, 2023. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product CIBINQO 100 mg Tablet, with a ceiling value of $4,384.17. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, with ID SPE2DB24D2101|SPE2DB25FKKET, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,623.19 firm fixed-price delivery order is for the supply of the prescription medication CIBINQO 100 MG TABLET, with a performance period ending on May 6, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,060.89 delivery order to AmerisourceBergen Drug Corp for CIBINQO 100 mg tablets (30-count units) with a completion deadline of July 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,519.08 awarded by the Defense Logistics Agency (DLA). The contract is for pharmaceutical and medical supply products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $15,278.28 delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU35GDelivery Order
This federal contract award, valued at $14,281.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of CIBINQO 100 MG TABLET UU 30S, with a performance period ending on July 13, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract awarded to Amerisourcebergen Drug Corp does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 7/12/23 |